Diagnosis and Management of Sarcopenia after Hip Fracture Surgery: Current Concept Review

Yoo, Jun‐Il; Kim, Jung-Taek; Park, Chan Ho; Cha, Yonghan

doi:10.5371/hp.2022.34.1.1

Cited by 11 publications

(6 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sarcopenia is related to adverse health outcomes (falls, disability, nursing home admission, and mortality). Several studies show an increasing epidemiological, biological, and clinical link between vulnerability, sarcopenia, osteoporosis, and falls, but there are no clear diagnostic criteria or treatment strategies in clinical practice [ 71 ].…”

Section: Reviewmentioning

confidence: 99%

The Effect of Postoperative Physical Therapy Following Hip Fracture: A Literature Review

Koudouna¹,

Evangelopoulos²,

Chronopoulos³

et al. 2023

Cureus

View full text Add to dashboard Cite

Hip fractures in the elderly have become a major public health concern as the population ages. Postoperative rehabilitation is associated with improved outcomes and a greater likelihood of returning to preoperative functional capacity. Several studies have been conducted to investigate various post-operative recovery pathways. However, little is known about which post-operative rehabilitation pathways for hip fractures are most effective in improving patient outcomes. No clear evidence-based guidelines for a standard mobilization protocol for patients are currently available. This review aims to investigate postoperative recovery pathways to help patients suffering from hip fracture return to pre-fracture condition and to quantify pre-operative and post-operative scores for objective rehabilitation evaluation. Measuring preoperative activity and comparing it to post-operative follow-up values can help predict post-operative rehabilitation functional outcomes.

show abstract

Section: Reviewmentioning

confidence: 99%

The Effect of Postoperative Physical Therapy Following Hip Fracture: A Literature Review

Koudouna¹,

Evangelopoulos²,

Chronopoulos³

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

“…[ 3 , 5 , 6 ] Sarcopenia is also recognized as a disease, and in 2016, it was officially included in the World Health Organization’s International Classification of Diseases, Tenth Revision with the disease code (M62.84), and South Korea also included it in the diagnosis code (M62.5) in 2021. [ 7 , 8 ]…”

Section: Introductionmentioning

confidence: 99%

“…[3,5,6] Sarcopenia is also recognized as a disease, and in 2016, it was officially included in the World Health Organization,s International Classification of Diseases, Tenth Revision with the disease code (M62.84), and South Korea also included it in the diagnosis code (M62.5) in 2021. [7,8] As the aging population becomes a global health concern, understanding the prevalence of sarcopenia in older adults is crucial for identifying the burden that this condition poses on individuals and healthcare systems. By estimating the prevalence of sarcopenia and identifying its associated risk factors and consequences, policymakers and healthcare professionals can develop targeted interventions to effectively prevent and manage sarcopenia, enhancing the overall health and well-being of older adults.…”

Section: Introductionmentioning

confidence: 99%

Recent Update on the Prevalence of Sarcopenia in Koreans: Findings from the Korea National Health and Nutrition Examination Survey

Kim,

Ha,

Kim

et al. 2024

J Bone Metab

Self Cite

View full text Add to dashboard Cite

Background: As recognized by the World Health Organization in 2016 with its inclusion in the International Classification of Diseases, Tenth Revision as M62.84, and by South Korea in 2021 as M62.5, the diagnostic guidelines for sarcopenia vary globally. Despite its prevalence in older populations, data on sarcopenia in Koreans aged 60 and above is scarce, highlighting the need for research on its prevalence in this demographic.Methods: Utilizing the 2022 Korea National Health and Nutrition Examination Survey dataset, sarcopenia was assessed among 1,946 individuals aged 60 or older according to the Asian Working Group for Sarcopenia 2019 criteria, incorporating grip strength and bioelectrical impedance analysis measurements. Statistical analyses were performed to differentiate categorical and continuous variables using logistic regression and Student’s t-tests, respectively.Results: The prevalence of sarcopenia was found to increase with age, with the highest prevalence observed in the oldest age group (80 years and older). The overall prevalence of sarcopenia in our study population was 6.8%. Among men, the prevalence of sarcopenia was 5.5% in the 60 or older age group, 9.6% in the 70 or older age group, and 21.5% in the 80 or older age group. Among women, the prevalence of sarcopenia was 7.9%, 10.5%, and 25.9%, respectively.Conclusions: This study highlights the significant burden of sarcopenia in elderly Koreans, particularly among the oldest individuals. These findings call for targeted interventions to manage and prevent sarcopenia, along with further research on its risk factors, consequences, and effective mitigation strategies.

show abstract

“…In 2016, sarcopenia was added to the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) by the United States, a global disease classification system published by the World Health Organization, and given a specific code (M62.84) [ 13 ]. The eighth revision of the Korean Classification of Diseases (KCD) in 2021 also included sarcopenia as a disease and assigned it an ICD-10-CM code (M62.5) [ 14 ].…”

Section: Introductionmentioning

confidence: 99%

Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review

Jang

Kim

2023

Biomedicines

View full text Add to dashboard Cite

Sarcopenia refers to the loss of muscle strength and mass in older individuals and is a major determinant of fall risk and impaired ability to perform activities of daily living, often leading to disability, loss of independence, and death. Owing to its impact on morbidity, mortality, and healthcare expenditure, sarcopenia in the elderly has become a major focus of research and public policy debates worldwide. Despite its clinical importance, sarcopenia remains under-recognized and poorly managed in routine clinical practice, partly owing to the lack of available diagnostic testing and uniform diagnostic criteria. Since the World Health Organization and the United States assigned a disease code for sarcopenia in 2016, countries worldwide have assigned their own disease codes for sarcopenia. However, there are currently no approved pharmacological agents for the treatment of sarcopenia; therefore, interventions for sarcopenia primarily focus on physical therapy for muscle strengthening and gait training as well as adequate protein intake. In this review, we aimed to examine the latest information on the epidemiology, molecular mechanisms, interventions, and possible treatments with new drugs for sarcopenia.

show abstract

Diagnosis and Management of Sarcopenia after Hip Fracture Surgery: Current Concept Review

Cited by 11 publications

References 36 publications

The Effect of Postoperative Physical Therapy Following Hip Fracture: A Literature Review

The Effect of Postoperative Physical Therapy Following Hip Fracture: A Literature Review

Recent Update on the Prevalence of Sarcopenia in Koreans: Findings from the Korea National Health and Nutrition Examination Survey

Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review

Contact Info

Product

Resources

About